Cytochalasin B

Drug Profile

Cytochalasin B

Alternative Names: Biostent; Preverex

Latest Information Update: 08 Jun 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Poniard Pharmaceuticals
  • Class Indoles; Macrolides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Coronary artery restenosis

Most Recent Events

  • 08 Jun 2000 A clinical study has been added to the Ischaemic Heart Disease pharmacodynamics section
  • 23 Mar 1999 Discontinued-I for Coronary artery restenosis in USA (Unknown route)
  • 16 May 1997 Phase-I clinical trials for Coronary artery restenosis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top